Brightlands Venture Partners IV holds €45m first close

Brightlands has a special focus on sustainability and health venture capital. To date, the firm has invested in 40 companies, helping them develop products and processes that address unmet needs in the areas of sustainability and health.

Noticeable investments inked by the firm include QC Polymers (mechanical recycling of commodity plastics); Ioniqa Technologies (chemical upcycling of PET); Black Bear Carbon and Fuenix (pyrolysis of used tyres and of mixed plastic waste); Neuroplast (treatment of paraplegia); Triplemed (aortic aneurysmas); and Matisse Pharmaceuticals (sepsis).

In addition to this new vehicle, the firm is currently managing three other funds: Chemelot Ventures; Brightlands Agrifood; and Limburg Ventures. 

Investors
The fund has four cornerstone investors: DSM Nederland, Provincie Limburg, LIOF and Rabo Corporate Investments.

In addition, €10m was provided by the Netherlands Enterprise Agency (RVO) for investments in the renewable chemistry space.

"After this first close, the fund will be open to additional professional investors who want to join us to make more impact," said Casper Bruens, managing partner of Brightlands.

"Brightlands backs renewable chemistry, regenerative medicine, agri-food and related digital technologies, areas where such impact is most needed," said Bruens.

Investments
BVP Fund IV will invest in renewable chemistry, regenerative medicine and agri-food. 

The vehicle will target startups and scale-ups in the Netherlands, Belgium, and in North Rhine Westphalia in Germany.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Funds
• Venture
• Benelux
• Technology
• Healthcare
• Netherlands
• Venture